Marker Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

CEO

Juan F. Vera

CEOJuan F. Vera

Employees

Employees5

Headquarters

Houston, Texas

HeadquartersHouston, Texas

Founded

1991

Founded1991

Employees

Employees5

MRKR Key Statistics

Market cap

17.67M

Market cap17.67M

Price-Earnings ratio

-1.18

Price-Earnings ratio-1.18

Dividend yield

—

Dividend yield—

Average volume

47.29K

Average volume47.29K

High today

—

High today—

Low today

—

Low today—

Open price

$1.60

Open price$1.60

Volume

0.00

Volume0.00

52 Week high

$5.99

52 Week high$5.99

52 Week low

$0.95

52 Week low$0.95

People also own

Based on the portfolios of people who own MRKR. This list is generated using Robinhood data, and it’s not a recommendation.